Optimizing malaria and HIV treatment in Africa
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live within about 30 km (18 miles) of the study clinic.
- You must agree to come to the clinic for all follow-up visits.
- You must have a negative blood test for malaria at the start of the study.
- If you are a child or teen with HIV, you must be on a specific HIV medicine (DTG) for at least 2 weeks.
- If you do not have HIV, you must have a test showing you are HIV-negative.
- You cannot be pregnant, have active tuberculosis, cancer, severe anemia, or other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This trial studies how artesunate works in infants under 2 years old being treated for severe malaria. It aims to learn more about the medicine to help improve treatment for babies.
This study looks for HIV drug resistance in people who have been on a specific first-line HIV medication (TLD) for at least 6 months and still have detectable virus. It aims to understand if resistance is developing so that better treatments can be planned.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
This study tests a new way to prevent malaria in children living in Busia District, Uganda. It combines malaria vaccines with preventive medicine to see if it offers better protection than current methods.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.